ROCKET PHARMACEUTICALS INC (RCKT) Stock Earnings & Estimates
USA - NASDAQ:RCKT - US77313F1066 - Common Stock
3.19 USD
-0.13 (-3.92%)
3.23 USD
+0.04 (+1.25%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 108.43% | N/A 4.86% | N/A 213.35% | N/A 72.73% | N/A 97.01% | N/A 103.40% | N/A 64.32% | ||||||||||||
| EBITDA YoY % growth | -7.7M | -20.35M -164.29% | -7.5M 63.14% | -19.57M -160.93% | -70.83M -261.93% | -75.72M -6.90% | -133.15M -75.85% | -161.88M -21.58% | -214.87M -32.73% | -249.7M -16.21% | -263.62M -5.57% | N/A 8.69% | N/A 7.37% | N/A 7.83% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -7.7M | -20.4M -164.94% | -7.57M 62.89% | -19.77M -161.16% | -71.16M -259.94% | -76.15M -7.01% | -134.3M -76.36% | -167.25M -24.53% | -221.14M -32.22% | -256.8M -16.13% | -273M -6.31% | N/A 7.90% | N/A 11.38% | N/A 0.24% | N/A 17.35% | N/A 26.21% | N/A 65.36% | N/A 407.10% | N/A 187.34% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -3.56 8.39% | -6.40 -79.78% | N/A | -1.88 | -1.58 15.96% | -2.51 -58.86% | -2.68 -6.77% | -3.29 -22.76% | -2.94 10.64% | -2.73 7.14% | N/A 22.06% | N/A 23.42% | N/A 18.39% | N/A 29.05% | N/A 28.65% | N/A 79.17% | N/A 645.45% | N/A 144.89% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.50 29.38% | -0.43 31.28% | -0.43 23.20% | -0.40 31.88% | -0.42 16.59% | -0.38 10.94% |
| Revenue Q2Q % growth | 283.336K | 283.336K | -100.00% | 4.878M 1,621.63% | ||
| EBITDA Q2Q % growth | -53.02M 14.47% | -44.584M 16.85% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -60.443M 12.40% | -53.863M 14.50% | -50.489M 21.11% | -50.841M 24.71% | -52.666M 12.87% | -48.707M 9.57% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.59 20.27% | -0.57 | -0.02 | -3.91% |
| Q1 2025 Q2Q % growth | -0.56 15.15% | -0.63 | 0.07 | 10.56% |
| Q4 2024 Q2Q % growth | -0.62 3.13% | -0.73 | 0.11 | 15.34% |
| Q3 2024 Q2Q % growth | -0.71 5.33% | -0.78 | 0.07 | 8.41% |
| Q2 2024 Q2Q % growth | -0.74 9.76% | -0.73 | -0.01 | -1.16% |
| Q1 2024 Q2Q % growth | -0.66 9.59% | -0.69 | 0.03 | 4.96% |
| Q4 2023 Q2Q % growth | -0.64 30.43% | -0.80 | 0.16 | 20.15% |
| Q3 2023 Q2Q % growth | -0.75 13.79% | -0.82 | 0.07 | 9.05% |
| Q2 2023 Q2Q % growth | -0.82 1.20% | -0.81 | -0.01 | -1.76% |
| Q1 2023 Q2Q % growth | -0.73 -8.96% | -0.87 | 0.14 | 15.97% |
| Q4 2022 Q2Q % growth | -0.92 -33.33% | -0.82 | -0.10 | -12.34% |
| Q3 2022 Q2Q % growth | -0.87 -10.13% | -0.81 | -0.06 | -8.07% |
| Q2 2022 Q2Q % growth | -0.83 -50.91% | -0.70 | -0.13 | -19.23% |
| Q1 2022 Q2Q % growth | -0.67 -3.08% | -0.72 | 0.05 | 7.48% |
| Q4 2021 Q2Q % growth | -0.69 36.11% | -0.78 | 0.09 | 11.41% |
| Q3 2021 Q2Q % growth | -0.79 -49.06% | -0.62 | -0.17 | -27.73% |
| Q2 2021 Q2Q % growth | -0.55 -22.22% | -0.66 | 0.11 | 16.93% |
| Q1 2021 Q2Q % growth | -0.65 -44.44% | -0.70 | 0.05 | 7.28% |
| Q4 2020 Q2Q % growth | -1.08 -176.92% | -0.52 | -0.56 | -105.78% |
| Q3 2020 Q2Q % growth | -0.53 -39.47% | -0.47 | -0.06 | -11.85% |
| Q2 2020 Q2Q % growth | -0.45 -18.42% | -0.52 | 0.07 | 12.74% |
| Q1 2020 Q2Q % growth | -0.45 -4.65% | -0.50 | 0.05 | 9.50% |
| Q4 2019 Q2Q % growth | -0.39 | -0.50 | 0.11 | 21.37% |
| Q3 2019 Q2Q % growth | -0.38 | -0.50 | 0.12 | 24.31% |
| Q2 2019 Q2Q % growth | -0.38 | -0.50 | 0.12 | 24.63% |
| Q1 2019 Q2Q % growth | -0.43 | -0.64 | 0.21 | 32.55% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 4.451M | -4.451M | -100.00% | |
| Q1 2025 Q2Q % growth | 1.898M | -1.898M | -100.00% | |
| Q4 2024 Q2Q % growth | 31.926K | -31.926K | -100.00% | |
| Q3 2024 Q2Q % growth | 719.1K | -719.1K | -100.00% | |
| Q4 2022 Q2Q % growth | 102K | -102K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.03% | 13.33% | 0% | 8.1% |
| Revenue | -11.11% | -14.89% | 0% | 11.4% |